Starsource Multitrade Ltd vs Zydus Lifesciences Limited

A side-by-side comparison of Starsource Multitrade Ltd (CHEMOPHARMALABORATORIESLTD) and Zydus Lifesciences Limited (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Zydus Lifesciences Limited leads CHEMOPHARMALABORATORIESLTD vs ZYDUSLIFE on 9 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation13
  • Profitability13
  • Growth· not comparable—
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

ZYDUSLIFE takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
22.42
8.55
P/B ratio
4.11
0.00%
Dividend yield
0.09%
₹2.27
EPS
₹50.09

Profitability

ZYDUSLIFE takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

0.28%
Return on equity
18.59%
5.17%
Return on capital
18.07%
28.57%
EBITDA margin
31.22%
28.57%
Net margin
18.87%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

—
Revenue CAGR (3Y) even
16.35%
—
Profit CAGR (3Y) even
34.80%

Size & financial health

ZYDUSLIFE takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹11 Cr
Market cap
₹1.12L Cr
₹0 Cr
Revenue
₹27,148 Cr
₹0 Cr
Net profit
₹5,124 Cr
0.00
Debt / equity
0.46
Starsource Multitrade Ltd
  • + ["Company is almost debt free."]
  • − ["Stock is trading at 8.46 times its book value", "Company has low interest coverage ratio.", "Promoter holding is low: 27.9%", "Company has a low return on equity of 5.09% over last 3 years.", "Company has high debtors of 337 days."]
Zydus Lifesciences Limited
  • + ["Company has delivered good profit growth of 18.6% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 20.9%"]
  • − []
Starsource Multitrade Ltd full analysis Zydus Lifesciences Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

CHEMOPHARMALABORATORIESLTD vs ZYDUSLIFE: Share Price, Valuation & Which to Buy | DocStoX